Pharmaceutical & biotech innovation, clarified.

Accelerate mission-critical pharmaceutical and biotech innovation with our powerful life sciences analytics experts. Get a cohesive view into macro-level health outcomes, understand clinical needs, and expedite clinical research with the most robust real-world data set in healthcare.

$35M

revenue growth in year-one

33%

more target HCPs identified

$300M

in new revenue potential

Life Sciences

OUTCOMES

Clarify’s solutions helped a global biopharma manufacturer:

Identify 13K+ patients suitable for newly-launched drug

Pinpoint 100+ physicians for potential outreach

Increase estimated revenue potential to $300M

Our most powerful solutions for life sciences:

Get Expertise

DEEP-DIVE INSIGHTS
RWD STUDIES

Receive expert advisory and conduct custom research on unique business questions pertaining to every aspect of healthcare

THE MOST COMPLEX CARE DECISIONS, CLARIFIED:

“Precisely assigning HCPs to deciles has been a game-changer for this launch. We are confident that reprioritizing our list was the right decision and we are now more effective with our outreach.”

Director, Oncology Analytics Division, Top 10 Pharma Company

Build your stack for pharmaceutical innovation.

Schedule a personalized demo today to learn how our building blocks help accelerate pharmaceutical development.

Schedule a demo

Insights

Advice for navigating the complexity of care decisions

Healthcare Insights

A real-world, claims-based study on anorexia epidemiology and mortality published by Pfizer and Clarify Health

Life Science Insights

Pfizer and Boehringer Ingelheim discuss the importance of real-world evidence

Life Science Insights

The Future of RWE in Clinical Trial Design and Recruitment

Healthcare Insights

Clinical Research News: Social Determinants Of Health Data Help Identify Sites For Trials

Life Science Insights

Is it enough? Pharma addresses DE&I in clinical trials

Life Science Insights

Will Pharma turn to tech for faster market access reporting?

Life Science Insights

The FDA now recommends that clinical trial sponsors submit a Race and Ethnicity Diversity Plan

Life Science Insights

Clarify publishes a study assessing differences in real-world medication adherence between Medicaid and commercial populations

Life Science Insights

Clarify publishes a real-world study on medication adherence among patients with a rare heart disease

Life Science Insights

Merck, Bristol-Myers Squibb, and Clarify discuss diversity in clinical trials

Life Science Insights

Pfizer leverages Clarify’s RWE to publish a study on diagnostic testing patterns for rare disease patients

Life Science Insights

The role of real-world evidence in the lifecycle of diagnostic, medical device, and digital therapeutic products

Life Science Insights

Pfizer, Novo Nordisk, Karius, and FibroGen discuss novel use cases for precision analytics

Life Science Insights

Dr. Calum MacRae talks about health equity in pharma

Life Science Insights

Diversity and inclusion in oncology clinical trials

Life Science Insights

Evaluating the impact of socioeconomic disparities on vaccination rates

Life Science Insights

Clarify’s CEO talks with PM360 about how pharma’s addressing health inequities with SDoH insights

Life Science Insights

The latest RWE trends from top 50 pharma

Life Science Insights

Using real-world evidence to improve commercialization strategy for rare disease drugs

Life Science Insights

Light up the patient journey with self-service analytics

Healthcare Analytics

Real-world applications of SDoH insights

Life Science Insights

The analytics your BD&L team could be missing

Life Science Insights

Pharma commercial leaders talk about decoding patient journeys

Life Science Insights

Clarify’s CEO talks with PM360 about pharma brand teams raising the bar

Life Science Insights

The traditional pharmaceutical commercialization model is outdated

Life Science Insights

Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile

Life Science Insights

Smarter therapy commercialization through insights leveraged by health plans and health systems

Life Science Insights

SBDoH Webinar: Separating Signals from Noise